[Federal Register Volume 62, Number 132 (Thursday, July 10, 1997)] [Notices] [Page 37071] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-18003] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Institute of Allergy and Infectious Diseases Special Emphasis Panel (SEP) meetings: Name of SEP: Energing Diseases Supplements. Date: July 30, 1997. Time: 2:00 p.m. to Adjournment. Place: Teleconference, 6003 Executive Boulevard, Solar Building, Room 3B05, Rockville, MD 20892, (301) 402-4988. Contact Person: Dr. Gary S. Modonna, Scientific Review Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C21, Bethesda, MD 20892, (301) 496-3528. Purpose/Agenda: To evaluate grant applications. Name of SEP: Emerging Diseases Supplements. Date: July 31, 1997. Time: 1:00 p.m. to Adjournment. Place: Teleconference, 6003 Executive Boulevard, Solar Building, Room 1A1, Rockville, MD 20892, (301) 496-0747. Contact Person: Dr. Gary S. Modonna, Scientific Review Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C21, Bethesda, MD 20892, (301) 496-3528. Purpose/Agenda: To evaluate grant applications. These meetings will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Programs Nos. 93.855, Immunology, Allergic and Immunologic Diseases Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health) Dated: July 1, 1997. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 97-18003 Filed 7-9-97; 8:45 am] BILLING CODE 4140-01-M